Biolife Sciences (Biolife Sciences) ROE % Adjusted to Book Value : 0.00% (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences ROE % Adjusted to Book Value?

Biolife Sciences's ROE % for the quarter that ended in May. 2008 was 0.00%. Biolife Sciences's PB Ratio for the quarter that ended in May. 2008 was N/A. Biolife Sciences's ROE % Adjusted to Book Value for the quarter that ended in May. 2008 was N/A.

Biolife Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Biolife Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences ROE % Adjusted to Book Value Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

ROE % Adjusted to Book Value

-1,996.43

-414.89

-1,714.29

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-41.75	-32.28	-3,828.14	-	-

Competitive Comparison of Biolife Sciences's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Biolife Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's ROE % Adjusted to Book Value falls into.

Biolife Sciences ROE % Adjusted to Book Value Calculation

Biolife Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Nov. 2007 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1,320.00%	/	0.77
	=	-1,714.29%

Biolife Sciences's ROE % Adjusted to Book Value for the quarter that ended in May. 2008 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Biolife Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020